Tissue Regenix Group (TRX) Competitors GBX 58.12 -1.38 (-2.31%) (As of 12/20/2024 08:06 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider Trades TRX vs. SFR, NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, and WPMShould you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Severfield (SFR), Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), and Wheaton Precious Metals (WPM). These companies are all part of the "precious metals" industry. Tissue Regenix Group vs. Severfield Nakama Group plc (NAK.L) (EGI.L) 532753 (IMG.L) 651814 (EDG.L) ArcelorMittal Nature Group Randgold Resources National Grid Wheaton Precious Metals Tissue Regenix Group (LON:TRX) and Severfield (LON:SFR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, community ranking, dividends, valuation and earnings. Does the media favor TRX or SFR? In the previous week, Severfield had 2 more articles in the media than Tissue Regenix Group. MarketBeat recorded 3 mentions for Severfield and 1 mentions for Tissue Regenix Group. Severfield's average media sentiment score of 0.55 beat Tissue Regenix Group's score of 0.00 indicating that Severfield is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tissue Regenix Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Severfield 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in TRX or SFR? Severfield received 64 more outperform votes than Tissue Regenix Group when rated by MarketBeat users. Likewise, 76.09% of users gave Severfield an outperform vote while only 69.53% of users gave Tissue Regenix Group an outperform vote. CompanyUnderperformOutperformTissue Regenix GroupOutperform Votes16269.53% Underperform Votes7130.47% SeverfieldOutperform Votes22676.09% Underperform Votes7123.91% Which has more risk and volatility, TRX or SFR? Tissue Regenix Group has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Severfield has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Do institutionals and insiders have more ownership in TRX or SFR? 37.0% of Tissue Regenix Group shares are owned by institutional investors. Comparatively, 66.9% of Severfield shares are owned by institutional investors. 47.3% of Tissue Regenix Group shares are owned by insiders. Comparatively, 4.4% of Severfield shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, TRX or SFR? Severfield has higher revenue and earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Severfield, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTissue Regenix Group£31.80M1.30-£1.10M-£0.01-5,812.50Severfield£463.46M0.34£15.90M£0.051,044.00 Is TRX or SFR more profitable? Severfield has a net margin of 3.43% compared to Tissue Regenix Group's net margin of -3.46%. Severfield's return on equity of 7.25% beat Tissue Regenix Group's return on equity.Company Net Margins Return on Equity Return on Assets Tissue Regenix Group-3.46% -3.31% 0.50% Severfield 3.43%7.25%4.69% SummarySeverfield beats Tissue Regenix Group on 12 of the 15 factors compared between the two stocks. Ad MyBankTrackerYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.View the best savings account rates here Get Tissue Regenix Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRX vs. The Competition Export to ExcelMetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£41.40M£164.65M£5.14B£1.88BDividend Yield4.12%3.64%5.09%5.54%P/E Ratio-5,812.50115.5190.051,810.29Price / Sales1.3018,239.951,117.14382,807.21Price / Cash5.7012.7543.0428.42Price / Book1.358.504.782.91Net Income-£1.10M-£20.67M£120.31M£156.83M7 Day Performance0.22%-1.04%-1.92%-1.92%1 Month Performance3.79%136.65%11.51%17.93%1 Year Performance6.85%137.57%30.61%29.50% Tissue Regenix Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRXTissue Regenix GroupN/AGBX 58.13-2.3%N/A+7.6%£41.40M£31.80M-5,812.50120News CoverageGap DownSFRSeverfieldN/AGBX 52.60-4.0%N/A-16.1%£158.03M£463.46M1,080.001,900News CoverageGap UpHigh Trading VolumeNAKNakama Group plc (NAK.L)N/AN/AN/A+0.0%£1.44M£8.09M-6.1353Gap DownHigh Trading VolumeEGI(EGI.L)N/AN/AN/AN/A£0.00N/A0.006Gap DownHigh Trading VolumeIMG532753 (IMG.L)N/AN/AN/AN/A£0.00N/A0.005,360High Trading VolumeEDG651814 (EDG.L)N/AN/AN/AN/A£0.00N/A0.002,610MTAArcelorMittalN/AN/AN/AN/A£0.00N/A0.009News CoverageHigh Trading VolumeNGRNature GroupN/AN/AN/AN/A£0.00N/A0.0010Gap UpRRSRandgold ResourcesN/AGBX 6,546+7,701,076.5%N/AN/A£0.00N/A0.0021,300News CoverageGap UpNGNational Grid2.0643 of 5 starsGBX 944.40+0.4%GBX 1,181.25+25.1%-12.6%£46.18B£19.85B1,717.0910High Trading VolumeWPMWheaton Precious Metals1.2393 of 5 starsGBX 4,790.51-0.4%GBX 5,200+8.5%+15.0%£21.73B£1.13B5,024.3842News CoveragePositive News Related Companies and Tools Related Companies SFR Competitors NAK Competitors EGI Competitors IMG Competitors EDG Competitors MTA Competitors NGR Competitors RRS Competitors NG Competitors WPM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRX Stock Alerts